Received Aug 15, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MNQ | MENINGOCOCCAL CONJUGATE (MENVEO) | NOVARTIS VACCINES AND DIAGNOSTICS | UNK | AMAB072A | — |
Liquid was not combined with the dry component.; Liquid was not combined with the dry component.; This non-serious case was reported by a other health professional via call center representative and described the occurrence of inappropriate dose of vaccine administered in a 11-year-old male patient who received Men ACWY-CRM NVS (Menveo) (batch number AMAB072A, expiry date 30-APR-2026) for prophylaxis. On 06-AUG-2025, the patient received Menveo. On 06-AUG-2025, an unknown time after receiving Menveo, the patient experienced inappropriate dose of vaccine administered (Verbatim: Liquid was not combined with the dry component.) and inappropriate preparation of medication (Verbatim: Liquid was not combined with the dry component.). The outcome of the inappropriate dose of vaccine administered and inappropriate preparation of medication were not applicable. Additional Information: GSK receipt date: 06-AUG-2025 The reporter asked was there any vaccine component in the liquid vial which was the vial 1 in the liquid or it was just saline? The reason why the reporter was asking was that the patient today was only given, they wasn't given the whole dosage cause they know that was supposed to be a combination 2 part the vaccine there and liquid was not combined with the dry component which led to inappropriate preparation of medication and Inappropriate dose of vaccine administration. The reporter did not realize few minutes ago was trying to see what steps they should take as this the first this has happened.